Skip to main content
Clinical Trials/CTRI/2024/07/070935
CTRI/2024/07/070935
Not yet recruiting
Phase 4

Restrictive vs Liberal fluid management in sepsis induced hypotension

Pt JNM Medical College Raipur CG1 site in 1 country364 target enrollmentStarted: July 30, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Pt JNM Medical College Raipur CG
Enrollment
364
Locations
1
Primary Endpoint
Death from any cause before discharge home or by day 90

Overview

Brief Summary

This is a prospective  randomized study to compare restrictive vs liberal fluid management in patient undergoing sepsis induce hypotension.A total number of 364 patient were enrolled in the study presenting to the CCU and will be randomized onto two two groups through sealed envelope techniques .Group A  with 182 patient receiving vasopressor as noradrenaline 5 ampoule till MAP is maintained greater than 65 mmHg Patient will be reassessed after one hour and if MAP is not maintain second vasopressor  as Vasopressin at the rate 2.4 ml/hour will be started and will be assessed till one hour. In Group B with 182 patient will receive 2 liters of bolus fluid over 1 hour followed by 2 liters over next 4 hour to maintain MAP >65 mmHg Primary outcome will be measured as Death from any cause brfore discharge or by day 90 and secndary outcomes measured will be in terms of days free from ventilator use,days free from renal replacement therapy,days free from vasopressor use, days out of CCU.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Adult patient from 18-65 years of age with sepsis induced hypotension confirmed through SIRS diagnostic criteria with MAP less than 65 mmHg.

Exclusion Criteria

  • Previous reception of greater 3000ml of IV fluid Elapse of greater than 6 hour on admission to hospital End stage renal failure Elevated jugular venous pressure Gastrointestinal bleeding in absence of fever congestive heart failure.

Outcomes

Primary Outcomes

Death from any cause before discharge home or by day 90

Time Frame: 90 days

Secondary Outcomes

  • Days free from ventilator use(90 days)
  • day free from renal replacement therapy(Day 90)
  • Days free from vasopressor use(Day 90)
  • Day out of CCU(By day 90)

Investigators

Sponsor
Pt JNM Medical College Raipur CG
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Anamika Tiwari

Pt. JNM medical college ,Dr. BRAM hospital raipur

Study Sites (1)

Loading locations...

Similar Trials